Diabetes Supply

Takeda Receives FDA Complete Response Letter for Alogliptin, an - PR Newswire
DEERFIELD, Ill., June 26, and OSAKA, Japan, June 27, 2009 /PRNewswire/ — Takeda Pharmaceutical Company Limited (”Takeda”) today announced that Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary received
Source: sev.prnewswire.com

This entry was posted on Wednesday, July 1st, 2009 at 12:00 pm and is filed under Diabetes Mellitus. You can subscribe via RSS 2.0 feed to this post's comments. You can skip to the end and leave a response. Pinging is currently not allowed.